Two Sigma Investments’s Inozyme Pharma INZY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $330K | Sell |
82,610
-5,483
| -6% | -$21.9K | ﹤0.01% | 2709 |
|
|
2025
Q1 | $80.2K | Buy |
88,093
+56,169
| +176% | +$51.1K | ﹤0.01% | 2929 |
|
|
2024
Q4 | $88.4K | Buy |
+31,924
| New | +$88.4K | ﹤0.01% | 2919 |
|
|
2024
Q2 | – | Sell |
-29,893
| Closed | -$229K | – | 3086 |
|
|
2024
Q1 | $229K | Sell |
29,893
-23,807
| -44% | -$182K | ﹤0.01% | 2589 |
|
|
2023
Q4 | $229K | Sell |
53,700
-14,400
| -21% | -$61.3K | ﹤0.01% | 2700 |
|
|
2023
Q3 | $286K | Sell |
68,100
-17,487
| -20% | -$73.4K | ﹤0.01% | 2433 |
|
|
2023
Q2 | $477K | Buy |
85,587
+20,087
| +31% | +$112K | ﹤0.01% | 2280 |
|
|
2023
Q1 | $375K | Buy |
65,500
+53,117
| +429% | +$304K | ﹤0.01% | 2249 |
|
|
2022
Q4 | $13K | Sell |
12,383
-800
| -6% | -$840 | ﹤0.01% | 2656 |
|
|
2022
Q3 | $35K | Buy |
+13,183
| New | +$35K | ﹤0.01% | 2295 |
|
|
2022
Q2 | – | Sell |
-10,916
| Closed | -$45K | – | 2651 |
|
|
2022
Q1 | $45K | Buy |
+10,916
| New | +$45K | ﹤0.01% | 2457 |
|